Your browser is no longer supported. Please, upgrade your browser.
Settings
AIPT Precision Therapeutics Inc. daily Stock Chart
AIPT [NASD]
Precision Therapeutics Inc.
Index- P/E- EPS (ttm)-0.78 Insider Own2.20% Shs Outstand14.73M Perf Week-15.01%
Market Cap8.18M Forward P/E- EPS next Y- Insider Trans- Shs Float13.33M Perf Month-28.91%
Income-10.10M PEG- EPS next Q- Inst Own3.10% Short Float4.08% Perf Quarter-40.46%
Sales1.40M P/S5.84 EPS this Y16.60% Inst Trans-3.39% Short Ratio6.65 Perf Half Y-37.64%
Book/sh0.00 P/B- EPS next Y- ROA-162.40% Target Price- Perf Year-43.38%
Cash/sh0.01 P/C40.88 EPS next 5Y- ROE-266.50% 52W Range0.46 - 1.58 Perf YTD-10.36%
Dividend- P/FCF- EPS past 5Y63.20% ROI-462.40% 52W High-64.56% Beta2.09
Dividend %- Quick Ratio0.30 Sales past 5Y24.70% Gross Margin70.50% 52W Low21.74% ATR0.07
Employees10 Current Ratio0.40 Sales Q/Q50.00% Oper. Margin- RSI (14)37.04 Volatility20.06% 9.20%
OptionableNo Debt/Eq16.00 EPS Q/Q-37.20% Profit Margin- Rel Volume0.55 Prev Close0.56
ShortableYes LT Debt/Eq0.00 EarningsApr 01 AMC Payout- Avg Volume81.80K Price0.56
Recom- SMA20-17.57% SMA50-24.41% SMA200-36.68% Volume21,576 Change0.90%
May-21-19 08:00AM  Precision Therapeutics Helomics Division Selected by AccuGenomics as Preferred Lab Partner for NIIMBL Grant GlobeNewswire
May-17-19 09:00AM  Precision Therapeutics Gains Extension for Nasdaq Compliance GlobeNewswire +25.72%
May-15-19 04:05PM  Precision Therapeutics Reports First Quarter 2019 Financial Results and Provides Corporate Update GlobeNewswire
02:30PM  Precision Therapeutics, Inc. to Host Earnings Call ACCESSWIRE
May-13-19 01:30PM  Precision Therapeutics to Report First Quarter 2019 Financial Results and Provide Company Update on Wednesday, May 15, 2019 GlobeNewswire -6.45%
Apr-18-19 08:45AM  Precision Therapeutics Subsidiary Helomics and National Alopecia Areata Foundation Sign Services Agreement to Provide Next-Generation Patient Registry for Alopecia Areata Research GlobeNewswire
Apr-16-19 08:45AM  Precision Therapeutics Subsidiary TumorGenesis and its Partner 48Hour Discovery Inc. Receive Alberta Innovates Product Demonstration Program Grant to Support Development of Novel Cancer Treatments GlobeNewswire
Apr-11-19 08:45AM  Precision Therapeutics Subsidiary, Helomics® Corporation, and SpeciCare, Inc. to Study Innovative Personalized Medicine Opportunities for Cancer Patients GlobeNewswire
08:00AM  Uptick Newswire Hosts Precision Therapeutics Inc. on The Stock Day Podcast to Discuss Massive Revenue Increases ACCESSWIRE
Apr-09-19 08:45AM  Precision Therapeutics Subsidiary Helomics to Collaborate with Viome to Explore the Impact of the Gut Microbiome on Ovarian Cancer GlobeNewswire
Apr-05-19 09:00AM  Precision Therapeutics Announces Completion of Merger with Helomics Holding Corporation GlobeNewswire +5.57%
Apr-01-19 04:10PM  Precision Therapeutics Reports Year End 2018 Financial Results and Provides Corporate Update GlobeNewswire
Mar-27-19 08:47AM  Precision Therapeutics Inc. Announces Pricing of Public Offering of Up to $1.2 Million of Units GlobeNewswire
Mar-26-19 04:40PM  Precision Therapeutics Inc. Announces Proposed Public Offering of Securities GlobeNewswire
Mar-25-19 05:15PM  Precision Therapeutics to Report Fiscal Year 2018 Financial Results and Provide Company Update on Monday, April 1, 2019 GlobeNewswire
05:15PM  Precision Therapeutics Announces Results of Special Meeting of Stockholders GlobeNewswire
Mar-21-19 09:00AM  Viome and Helomics Partner to Identify Personalized Treatment for Ovarian Cancer Patients PR Newswire
Mar-14-19 08:30AM  Precision Therapeutics Extends Exchange Offer for Helomics Notes and Warrants GlobeNewswire
Mar-05-19 08:30AM  Precision Therapeutics Skyline Medical Division Captures Market Share in Saudi Arabia Via New Orders While Disposable Sales Show Significant Year-Over-Year Increase GlobeNewswire
Mar-01-19 01:44PM  Dawson James Securities Announces the Closing of Public Offering for Precision Therapeutics Inc. GlobeNewswire
Feb-27-19 08:36AM  Precision Therapeutics Inc. Announces Pricing of Public Offering of Up to $1.26 Million of Units GlobeNewswire +7.78%
Feb-26-19 05:15PM  Precision Therapeutics Inc. Announces Proposed Public Offering of Securities GlobeNewswire
Feb-19-19 08:45AM  Precision Therapeutics Inc. is Excited to Announce a Special Meeting of Stockholders and Commencement of Registered Exchange Offer GlobeNewswire
Feb-07-19 08:45AM  Precision Therapeutics Skyline Medical Division Expands Presence in Australia with Three New STREAMWAY Systems at Wangaratta Hospital in Victoria GlobeNewswire
Feb-05-19 08:45AM  Precision Therapeutics TumorGenesis Division Isolates Discovery Biomarkers for Thyroid Cancer Cell Types, Initiating Its Proprietary Process for New Drug Development Via Patient-Derived Tumor Models GlobeNewswire
Jan-25-19 08:30AM  Precision Therapeutics Skyline Medical Division Widens Global Reach Through New Taiwanese Distribution Agreement with Winner Scientific GlobeNewswire
Jan-22-19 10:00AM  Precision Therapeutics Has Groundbreaking Approach to Personalized Cancer Treatment, Reports CEOCFO Magazine ACCESSWIRE
Jan-18-19 08:45AM  Precision Therapeutics Receives $1,370,000 Investment from CEO and Director, Carl Schwartz GlobeNewswire
Jan-17-19 08:45AM  Precision Therapeutics Skyline Medical Division Significantly Expands Footprint in New England With Sale of Six STREAMWAY Systems to Yale University Ambulatory Outpatient Surgical Center GlobeNewswire +12.47%
Nov-14-18 04:15PM  Precision Therapeutics Reports Third Quarter 2018 Financial Results GlobeNewswire
08:30AM  Helomics Corp Partners with UK 100,000 Genomes Project to Drive its Artificial Intelligence-Powered Precision Oncology Platform for Ovarian Cancer GlobeNewswire
Nov-08-18 08:30AM  Precision Therapeutics to Hold Business Update Conference Call on November 14, 2018 GlobeNewswire
Nov-07-18 08:30AM  Precision Therapeutics Secures Rights to Novel Technology Designed To Develop Drugs That Target Specific Cancer by Its Mutation GlobeNewswire
Nov-05-18 08:30AM  Precision Therapeutics CEO Talks with Uptick Newswires Stock Day Podcast About Exciting New Breakthroughs in Tumor Treatment and Whats on the Horizon GlobeNewswire
Oct-29-18 08:05PM  Filing under Rule 425 under the Securities Act of 1933 and deemed filed under Rule 14a-12 of the Securities Exchange Act of 1934 Filing by: Precision Therapeutics Inc.: SEC File Nos. 001-36790; and 333-221966 GlobeNewswire
Oct-11-18 08:30AM  Precision Therapeutics Continues to Build World Class Scientific Advisory Board with Appointment of Hector J. Gomez, MD, PhD GlobeNewswire
Oct-09-18 08:30AM  Precision Therapeutics Skyline Medical Division Signs International Distribution Agreement with India-based Prenit World GlobeNewswire
Sep-27-18 08:30AM  Precision Therapeutics Secures First STREAMWAY System Sale in Europe GlobeNewswire +6.00%
Sep-25-18 05:15PM  Dr. Bob Murphy, Head of Computational Biology at Carnegie Mellon University, Joins Precision Therapeutics Scientific Advisory Board GlobeNewswire
Sep-13-18 05:15PM  Precision Therapeutics Bolsters Scientific Advisory Board with the Appointment of Dr. Paul Kornblith GlobeNewswire
Sep-11-18 08:30AM  Precision Therapeutics Appoints Dr. Amelia Warner to Scientific Advisory Board GlobeNewswire
Sep-06-18 09:00AM  Precision Therapeutics Forms Scientific Advisory Board to Advance its Strategy in the Precision Medicine Sector GlobeNewswire
Aug-14-18 04:15PM  Precision Therapeutics Reports Second Quarter 2018 Financial Results GlobeNewswire
02:30PM  Skyline Medical, Inc. to Host Earnings Call ACCESSWIRE
08:00AM  Precision Therapeutics Investee, Helomics Corporation, Announces Commercial Launch of New HelomicsDiscover Program to Drive Forward the Next Generation of Precision Cancer Therapies GlobeNewswire
Aug-09-18 08:30AM  Precision Therapeutics Investee, Helomics Corporation, Launches Precision Oncology Insights Platform GlobeNewswire
Aug-08-18 05:15PM  Precision Therapeutics to Hold Business Update Conference Call on August 14, 2018 GlobeNewswire
Aug-07-18 10:55AM  Precision Therapeutics Making Rapid Progress with Both Personalized Medicine and Unique Medical Waste Disposal System GlobeNewswire
Aug-01-18 06:00PM  Precision Therapeutics Receives Approval of Delisting Request from German Stock Exchange GlobeNewswire
Jul-17-18 10:00AM  Precision Therapeutics Merger with Helomics Corp. Accelerates Personalized Cancer Treatment Strategies ACCESSWIRE +5.79%
Jul-12-18 08:00PM  Precision Therapeutics Granted European Patent for its Automated, Direct-to-Drain Medical Fluid Disposal System GlobeNewswire
Jun-28-18 07:00PM  Precision Therapeutics Signs Definitive Merger Agreement with Helomics Holding Corporation GlobeNewswire
May-31-18 08:30AM  Precision Therapeutics Launches New Website GlobeNewswire +17.12%
May-15-18 04:15PM  Precision Therapeutics Reports First Quarter 2018 Financial Results GlobeNewswire
May-10-18 08:30AM  Precision Therapeutics Projects Meaningful STREAMWAY System Sales in Europe in the Second Half of 2018 GlobeNewswire
May-08-18 08:30AM  Precision Therapeutics to Hold Business Update Conference Call on May 15, 2018 GlobeNewswire
Apr-23-18 08:30AM  Precision Therapeutics, Inc. Signs Letter of Intent to Purchase Remainder of Helomics Corporation Shares GlobeNewswire -6.07%
Apr-09-18 08:30AM  Precision Therapeutics, Inc. Engages Richard Gabriel to Drive Business Development Strategy for its TumorGenesis Subsidiary GlobeNewswire
Apr-04-18 07:00PM  CORRECTING and REPLACING - Precision Therapeutics Releases Highlights from FY 2017 Business Update Call GlobeNewswire +24.69%
12:16PM  Precision Therapeutics is the First Company to Grow Cancer Cells in the Lab That React Like Tumors Inside the Body -- CEOLIVE.TV GlobeNewswire
08:30AM  Precision Therapeutics Releases Highlights from FY 2017 Business Update Call GlobeNewswire
Apr-02-18 04:15PM  Precision Therapeutics Reports Fiscal Year 2017 Financial Results GlobeNewswire
Mar-29-18 08:30AM  Precision Therapeutics Announces Record STREAMWAY® System Sales in the First Three Months of 2018 GlobeNewswire
Mar-26-18 08:30AM  Precision Therapeutics to Hold Business Update Conference Call on April 2, 2018 GlobeNewswire
Mar-21-18 08:30AM  Precision Therapeutics Subsidiary, TumorGenesis, Announces License Agreement with CellBridge Incorporated GlobeNewswire +5.61%
Mar-15-18 04:30PM  Precision Therapeutics Subsidiary, TumorGenesis, Announces License Agreement with 48Hour Discovery GlobeNewswire
Mar-14-18 04:30PM  Precision Therapeutics Increases Equity Stake in Helomics to 25% GlobeNewswire -6.62%
Mar-13-18 08:30AM  Precision Therapeutics Subsidiary, TumorGenesis, Announces License Agreement with SyntArray, LLC GlobeNewswire
Mar-12-18 04:30PM  Precision Therapeutics Appoints Kevin Hungerford as Vice President of Sales and Marketing GlobeNewswire
Feb-27-18 08:30AM  Precision Therapeutics Forms TumorGenesis Inc. Subsidiary to Focus on the Next Generation of Patient Derived Tumor Models GlobeNewswire
Precision Therapeutics Inc. provides various healthcare products and services primarily in the United States. The company manufactures environmentally conscious systems for the collection and disposal of infectious fluids that result from surgical procedures and post-operative care. It offers the STREAMWAY Fluid Waste Management system that suctions surgical waste fluid from the patient using standard surgical tubing; and disposables. The company also provides contract research organization (CRO) that offers personalized medicine solutions for pharmaceutical, diagnostic, and biotech industries. Its CRO services enhance the effectiveness of cancer therapy using the power of artificial intelligence applied to diseases databases. The company markets and sells its STREAMWAY Fluid Waste Management system and procedure disposables to medical facilities through various direct sales force and independent distributors. The company was formerly known as Skyline Medical Inc. and changed its name to Precision Therapeutics Inc. in February 2018. Precision Therapeutics Inc. was founded in 2002 and is based in Eagan, Minnesota.